Name | Crexavibart |
---|
Description | Crexavibart (BMS-986413; C-144-LS) is an IgG1λ2 antibody that targets the SARS-CoV2 spike (S) glycoprotein receptor-binding domain[1]. |
---|---|
Related Catalog | |
Target |
SARS-CoV2[1] |
No Any Chemical & Physical Properties |